1. MAPK/ERK Pathway Autophagy Apoptosis Immunology/Inflammation NF-κB Metabolic Enzyme/Protease
  2. p38 MAPK Autophagy Apoptosis Reactive Oxygen Species (ROS) NF-κB Bcl-2 Family
  3. Hesperetin

Hesperetin is a natural flavanone that can be found in citrus, and acts as a potent and orally active broad-spectrum inhibitor against human UGT activity. Hesperetin induces apoptosis via p38 MAPK activation. Hesperetin displays a range of bioactivities including antioxidant, anti-inflammatory, and anti-cancer. Hesperetin is found to induce cell-cycle arrest at G2/M phase. Hesperetin can reduce Bcl-2 and enhance BaxM. Hesperetin induces apoptosis through inhibiting NF-κB receptor.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号 : 520-33-2

容量 価格(税別) 在庫状況 数量
>無料サンプル (0.1 - 0.2 mg)   今すぐ申し込む  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 72 在庫あり
Solution
10 mM * 1 mL in DMSO USD 72 在庫あり
Solid
50 mg $66 在庫あり
100 mg $80 在庫あり
200 mg   お問い合わせ  
500 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 25 publication(s) in Google Scholar

Other Forms of Hesperetin:

Top Publications Citing Use of Products

    Hesperetin purchased from MedChemExpress. Usage Cited in: Nutr Cancer. 2020;72(3):538-545.  [Abstract]

    U-251 cells are cultured with indicated concentration of Hesperetin for 24 h. Then the cells are stained with DAPI and observed under a fluorescence microscope.

    Hesperetin purchased from MedChemExpress. Usage Cited in: Nutr Cancer. 2020;72(3):538-545.  [Abstract]

    The expression of Bax and Bcl-2 was examined by western blotting. GAPDH was served as a loading control.

    Hesperetin purchased from MedChemExpress. Usage Cited in: Nutr Cancer. 2020;72(3):538-545.  [Abstract]

    Hesperetin induced G2/M arrest in GBM cell. Cells are treated with vehicle or various doses of hesperetin for 24 h. Whole cell lysates are immunoblotted with indicated antibodies. The protein levels of p21, CDK1, and cyclin B1 are measured by western blotting.

    Hesperetin purchased from MedChemExpress. Usage Cited in: Nutr Cancer. 2020;72(3):538-545.  [Abstract]

    p38 MAPK activation is involved in Hesperetin-induced apoptosis. The phosphorylation of p38 MAPK, JNK, and ERK in U-21 cells treated with hesperetin is analyzed by western blotting.

    p38 MAPK アイソフォーム固有の製品をすべて表示:

    NF-κB アイソフォーム固有の製品をすべて表示:

    Bcl-2 Family アイソフォーム固有の製品をすべて表示:

    • 生物活性

    • 純度とドキュメンテーション

    • 参考文献

    • カスタマーレビュー

    製品説明

    Hesperetin is a natural flavanone that can be found in citrus, and acts as a potent and orally active broad-spectrum inhibitor against human UGT activity. Hesperetin induces apoptosis via p38 MAPK activation. Hesperetin displays a range of bioactivities including antioxidant, anti-inflammatory, and anti-cancer. Hesperetin is found to induce cell-cycle arrest at G2/M phase. Hesperetin can reduce Bcl-2 and enhance BaxM. Hesperetin induces apoptosis through inhibiting NF-κB receptor[1][2][3][4].

    Cellular Effect
    Cell Line Type Value Description References
    BJ EC50
    > 10 μM
    Compound: 3
    Cytotoxicity against human BJ cells assessed as viable cells after 72 hrs by calcein AM assay
    Cytotoxicity against human BJ cells assessed as viable cells after 72 hrs by calcein AM assay
    [PMID: 20192247]
    CCRF-CEM EC50
    > 10 μM
    Compound: 3
    Cytotoxicity against human CEM cells assessed as viable cells after 72 hrs by calcein AM assay
    Cytotoxicity against human CEM cells assessed as viable cells after 72 hrs by calcein AM assay
    [PMID: 20192247]
    Caco-2 IC50
    66.67 μM
    Compound: 28
    Cytotoxicity in human Caco2 cells after 72 hrs by MTT assay
    Cytotoxicity in human Caco2 cells after 72 hrs by MTT assay
    [PMID: 28793973]
    HCT-116 GI50
    36.1 μM
    Compound: Hesperetin
    Anticlonogenic activity in human HCT116 cells after 6 days by crystal violet staining based assay
    Anticlonogenic activity in human HCT116 cells after 6 days by crystal violet staining based assay
    [PMID: 27840137]
    HeLa EC50
    > 10 μM
    Compound: 3
    Cytotoxicity against human HeLa cells assessed as viable cells after 72 hrs by calcein AM assay
    Cytotoxicity against human HeLa cells assessed as viable cells after 72 hrs by calcein AM assay
    [PMID: 20192247]
    MCF7 EC50
    > 10 μM
    Compound: 3
    Cytotoxicity against human MCF7 cells assessed as viable cells after 72 hrs by calcein AM assay
    Cytotoxicity against human MCF7 cells assessed as viable cells after 72 hrs by calcein AM assay
    [PMID: 20192247]
    Monocyte IC50
    2.1 x 10-6 M
    Compound: hesperetin
    Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression after 18 hrs
    Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression after 18 hrs
    [PMID: 8882428]
    PC-3 IC50
    40 μM
    Compound: Hesperetin
    Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
    Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
    [PMID: 31398616]
    PC-3 IC50
    90 μM
    Compound: Hesperetin
    Antiproliferative activity against human PC3 cells after 24 hrs by MTT assay
    Antiproliferative activity against human PC3 cells after 24 hrs by MTT assay
    [PMID: 31398616]
    RAW264.7 CC50
    > 100 μM
    Compound: 16
    Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
    Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
    [PMID: 33667099]
    RAW264.7 IC50
    31.2 μM
    Compound: 16
    Inhibition of LPS induced NO production in mouse RAW264.7 cells measured after 24 hrs by Griess reagent based assay
    Inhibition of LPS induced NO production in mouse RAW264.7 cells measured after 24 hrs by Griess reagent based assay
    [PMID: 33667099]
    RAW264.7 IC50
    48.59 μM
    Compound: 1; Hes
    Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production preincubated for 2 hrs followed by LPS stimulation and measured after 24 hrs by Griess method
    Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production preincubated for 2 hrs followed by LPS stimulation and measured after 24 hrs by Griess method
    [PMID: 33493826]
    RPMI-8226 EC50
    > 10 μM
    Compound: 3
    Cytotoxicity against human RPMI8226 cells assessed as viable cells after 72 hrs by calcein AM assay
    Cytotoxicity against human RPMI8226 cells assessed as viable cells after 72 hrs by calcein AM assay
    [PMID: 20192247]
    THP-1 EC50
    > 10 μM
    Compound: 3
    Cytotoxicity against human THP1 cells after 72 hrs by erythosin B staining method
    Cytotoxicity against human THP1 cells after 72 hrs by erythosin B staining method
    [PMID: 20192247]
    U-266 EC50
    > 10 μM
    Compound: 3
    Cytotoxicity against human U266 cells assessed as viable cells after 72 hrs by calcein AM assay
    Cytotoxicity against human U266 cells assessed as viable cells after 72 hrs by calcein AM assay
    [PMID: 20192247]
    Vero IC50
    8.3 μM
    Compound: Hesperetin
    Inhibition of SARS coronavirus 3C-like protease cis-cleavage activity transfected in african green monkey Vero cells by luciferase reporter gene assay
    Inhibition of SARS coronavirus 3C-like protease cis-cleavage activity transfected in african green monkey Vero cells by luciferase reporter gene assay
    [PMID: 23647823]
    体外実験

    Hesperetin (Compound HET) (100 μM) results in strong or moderate inhibition on 10 tested rhUGT isoforms[2].
    Hesperetin (100-800 μM, 24-48 h) significantly reduces the viabilities of U-251 and U-87 cells in a time- and concentration-dependent manner[4].
    Hesperetin (200-400 μM, 24 h) significantly increases the proportion of apoptotic cells in a dose-dependent manner in U-251 cells[4].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Immunofluorescence[4]

    Cell Line: U-251 cell line
    Concentration: 200 and 400 μM
    Incubation Time: 24 h
    Result: Resulted in significant accumulation of cell populations at the G2/M phase, with a concomitant decrease of cell populations in G1 phase and a slightly elevated population in S phase.

    Cell Viability Assay[4]

    Cell Line: U-251 and U-87 cells
    Concentration: 100, 200, 400, 600, and 800 μM
    Incubation Time: 24 and 48 h
    Result: Significantly reduced the viabilities of U-251 and U-87 cells in a time- and concentration-dependent manner with IC50s of 468.33 μM and 441.87 μM.
    体内実験

    Hesperetin (Compound Hp) (40 mg/kg, p.o., 21 d) reversed the activities of AChE to near normal in Cd-exposed rats[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Cd-exposed male albino Wistar rats (180-210 g)[3]
    Dosage: 40 mg/kg
    Administration: Oral gavage (p.o.)
    Result: Significantly reversed the activities of AChE to near normal.
    Decreased the levels of LPO products in brain.
    Significantly increased the levels of antioxidants in brain.
    Significantly increased the activities of ATPases enzymes in brain.
    Decreased the levels of Bax, cytochrome c, caspase 3 and 9 and increased the levels of Bcl2 markers.
    Significantly restores the activities of mitochondrial enzyme complex I, II, III and IV.
    Restored the levels of NO and OH-.
    Restored the enzyme activities in cererbrum.
    Reduced the tail length, tail moment, and tail intensity.
    臨床実験
    分子量

    302.28

    分子式

    C16H14O6

    CAS 番号
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    O=C1C[C@@H](C2=CC=C(OC)C(O)=C2)OC3=CC(O)=CC(O)=C13

    Structure Classification
    Initial Source
    輸送条件

    Room temperature in continental US; may vary elsewhere.

    保管条件
    Powder -20°C 3 years
      4°C 2 years
    In solvent -80°C 6 months
      -20°C 1 month
    溶剤 & 溶解度
    体外: 

    DMSO : 125 mg/mL (413.52 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 3.3082 mL 16.5410 mL 33.0819 mL
    5 mM 0.6616 mL 3.3082 mL 6.6164 mL
    10 mM 0.3308 mL 1.6541 mL 3.3082 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始)

    C1

    ×
    体積 (開始)

    V1

    =
    濃度 (終了)

    C2

    ×
    体積 (終了)

    V2

    体内:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.5 mg/mL (8.27 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 2.5 mg/mL (8.27 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.

    For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  0.5% CMC/saline water

      Solubility: 20 mg/mL (66.16 mM); Suspended solution; Need ultrasonic

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    純度とドキュメンテーション

    純度: 99.12%

    参考文献

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 3.3082 mL 16.5410 mL 33.0819 mL 82.7048 mL
    5 mM 0.6616 mL 3.3082 mL 6.6164 mL 16.5410 mL
    10 mM 0.3308 mL 1.6541 mL 3.3082 mL 8.2705 mL
    15 mM 0.2205 mL 1.1027 mL 2.2055 mL 5.5137 mL
    20 mM 0.1654 mL 0.8270 mL 1.6541 mL 4.1352 mL
    25 mM 0.1323 mL 0.6616 mL 1.3233 mL 3.3082 mL
    30 mM 0.1103 mL 0.5514 mL 1.1027 mL 2.7568 mL
    40 mM 0.0827 mL 0.4135 mL 0.8270 mL 2.0676 mL
    50 mM 0.0662 mL 0.3308 mL 0.6616 mL 1.6541 mL
    60 mM 0.0551 mL 0.2757 mL 0.5514 mL 1.3784 mL
    80 mM 0.0414 mL 0.2068 mL 0.4135 mL 1.0338 mL
    100 mM 0.0331 mL 0.1654 mL 0.3308 mL 0.8270 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    質量   濃度   体積   分子量 *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    最近チェックした製品:

    オンラインお問い合わせ

    Your information is safe with us. * Required Fields.

    製品名

     

    カスタマ需要量 *

    お名前 *

     

    タイトル

    メールアドレス *

     

    電話番号 *

    デパートメント

     

    組纖名 *

    市区町村

    都道府県

    国或いは地域 *

         

    必ず会社名を記載ください。個人への返信は行いません。

    備考

    バルクお問い合わせ

    Inquiry Information

    製品名:
    Hesperetin
    製品番号:
    HY-N0168
    数量:
    MCE 日本正規代理店: